| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2880940 | The Annals of Thoracic Surgery | 2008 | 8 Pages |
Abstract
Among patients undergoing CABG in this registry, aprotinin use was associated with increased renal failure and higher mortality through 12 years in a propensity-stratified analysis. The increased mortality may be related to higher concentrations of aprotinin received.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Stephen A. DO, Peter H.U. MD, MPH, Tamar CCP, Sabina A. MPH, James MD, George MD,